UNSPSC 85251702: Diagnosis of malignant neoplasm on the middle ear

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Middle ear. Malignant neoplasm on the Middle ear is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C30. 1

UNSPSC 85251702 Diagnosis of malignant neoplasm on the middle ear is a Commodity code that shows minimal alignment with recent state and local procurement activity. The three most recent opportunities posted under this code do not address malignant neoplasm diagnosis specifically; instead, they reflect broader health system needs: San Mateo Medical Center's October 2026 RFP for Diagnostic Imaging PACS (Picture Archiving and Communication System) implementation, Birdville Independent School District's October 2026 RFP for special education contracted services including speech language therapists and audiologists, and Santa Clara County Health System's July 2026 RFQ establishing a qualified vendor pool for temporary health professional staffing in ancillary clinical categories including audiology and diagnostic imaging. The code's nominal scope—diagnosis of a specific malignancy in the ear—does not reflect the diagnostic imaging infrastructure, educational support services, and temporary clinical staffing that state and local buyers are actually procuring under this classification.

Recent activity shows issuing bodies including county health systems, independent school districts, and public hospital networks across California and Texas. The San Mateo Medical Center opportunity, with a response date of October 21, 2026, solicits enterprise-grade PACS with EPIC integration supporting 65,000 annual radiology studies and 5,000 cardiology studies, with 99.9% uptime requirements and nine to twelve-month implementation windows. Santa Clara County Health System's October 7, 2026 deadline targets a five-year qualified vendor pool for diagnostic imaging and radiology staffing on a non-exclusive, multiple-award basis with no guaranteed work volume. This code appears to capture health system diagnostic and ancillary service procurement broadly rather than focused neoplasm diagnosis, and the recent opportunities provide little signal of demand specific to malignant ear pathology diagnosis.